References
Eskian M, Alavi A, Khorasanizadeh M, Viglianti BL, Jacobsson H, Barwick TD, et al. Effect of blood glucose level on standardized uptake value (SUV) in 18F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements. Eur J Nucl Med Mol Imaging. 2019;46:224–37. https://doi.org/10.1007/s00259-018-4194-x.
Fahey FH, Kinahan PE, Doot RK, Kocak M, Thurston H, Poussaint TY. Variability in PET quantitation within a multicenter consortium. Med Phys. 2010;37:3660–6. https://doi.org/10.1118/1.3455705.
Sprinz C, Zanon M, Altmayer S, Watte G, Irion K, Marchiori E, et al. Effects of blood glucose level on 18F fluorodeoxyglucose (18F-FDG) uptake for PET/CT in normal organs: an analysis on 5623 patients. Sci Rep. 2018;8:2126. https://doi.org/10.1038/s41598-018-20529-4.
Sprinz C, Altmayer S, Zanon M, Watte G, Irion K, Marchiori E, et al. Effects of blood glucose level on 18F-FDG uptake for PET/CT in normal organs: a systematic review. PLoS One. 2018;13:e0193140. https://doi.org/10.1371/journal.pone.0193140.
Turcotte E, Leblanc M, Carpentier A, Bénard F. Optimization of whole-body positron emission tomography imaging by using delayed 2-Deoxy-2-[F-18]fluoro-d-glucose injection following I.V. Insulin in diabetic patients. Mol Imaging Biol. 2006;8:348–54. https://doi.org/10.1007/s11307-006-0064-1.
Caobelli F, Pizzocaro C, Paghera B, Guerra UP. Proposal for an optimized protocol for intravenous administration of insulin in diabetic patients undergoing 18F-FDG PET/CT. Nucl Med Commun. 2013;34:271–5. https://doi.org/10.1097/MNM.0b013e32835d1034.
Büsing KA, Schönberg SO, Brade J, Wasser K. Impact of blood glucose, diabetes, insulin, and obesity on standardized uptake values in tumors and healthy organs on 18 F-FDG PET / CT. Nucl Med Biol. 2013;40:206–13. https://doi.org/10.1016/j.nucmedbio.2012.10.014.
Delbeke D, Coleman RE, Guiberteau MJ, Brown ML, Royal HD, Siegel BA et al. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med. 2006;47:885–95.
Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328–54. https://doi.org/10.1007/s00259-014-2961-x.
ACR Guidelines and Standards Committee. ACR-SPR practice parameter for performing FDG-PET/CT in oncology. American College of Radiology; 2018. http://www.acr.org/∼/media/71B746780F934F6D8A1BA5CCA5167EDB.pdf. Accessed 28 Jan 2018.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors report no relationships that could be construed as a conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 498 kb)
Rights and permissions
About this article
Cite this article
Altmayer, S., Zanon, M., Sprinz, C. et al. Is the effect of hyperglycemia on liver 18F-FDG standardized uptake value really clinically significant?. Eur J Nucl Med Mol Imaging 46, 1216–1217 (2019). https://doi.org/10.1007/s00259-019-04288-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-019-04288-6